Trump Announces Emergency Authorization For Use of Convalescent Plasma to Treat Coronavirus
On Sunday, President Trump held a press conference, where he announced that the FDA issued an emergency authorization for using convalescent plasma to treat coronavirus.
Joined by FDA commissioner Dr. Stephen Hahn and HHS Secretary Alex Azar, Trump said that “[T]oday’s action will dramatically expand access to this treatment.”
Trump also added that Operation Warpspeed helped to produce new treatments faster, and that the authorization is a way of fighting “the virus by “marshaling the full power and authority of the federal government.”
People who have recovered from the virus have many antibodies in their blood plasma, which can help others fight the virus.
Hence, Azar said that “[I]f you donate plasma you could save a life.”
Trump also urged people who recovered from the virus to donate their blood plasma.
According to the New York Post, the authorization of the treatment is based “primarily on preliminary data from a Mayo Clinic-led study that was part of an ‘expanded-access program’ sponsored by the FDA to speed up access to experimental therapy.”
The Post continues that “[M]ore than 70,000 coronavirus patients in the US have been treated with blood plasma. Preliminary data from 35,000 of them found there were fewer deaths among those given the treatment within the first three days of diagnosis and also among those given plasma with the highest levels of virus-fighting antibodies.”
Trump’s authorization of this treatment might indeed be a game-changing strategy in combatting the coronavirus. Let’s hope that it works, and that the pandemic ends soon.